HongShan-backed OnCusp Therapeutics snags $100m Series A
OnCusp Therapeutics has raised $100 million in a Series A funding round co-led by Novo Holdings, OrbiMed, and F-Prime Capital.
Source: dealstreetasia.com
📰 Sandy Fu News
Sandy Fu News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sandy Fu. Real-time updates on events, politics, business and more.
Marin DA's office in turmoil amid lawsuits, staff attrition, case backlog
The lawsuits against Marin County District Attorney Lori Frugoli and key staffers could cost millions of dollars in damages or settlements.
Source: pressdemocrat.com
OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies
Press release content from PR Newswire. The AP news staff was not involved in its creation. OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies June 30, 2021 GMT NEW YORK, June 29, 2021 /PRNewswire/ -- OnCusp Therapeutics (or “OnCusp”), a global biopharmaceutical company focused on translating cutting-edge research assets into innovative oncology therapeutics, announced that it has officially commenced operations both in New York and Shanghai. OnCusp successful...
Source: apnews.com